Delivery Order SPE2DB24D9131-SPE2DB25FXRT0
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,162.88 by the Defense Logistics Agency on September 23, 2025, for the supply of Xolair 300 mg/2 ml syringes. The contract, which carries a firm fixed-price structure with no set-aside designation, is scheduled for ultimate completion by October 15, 2025, and will be performed at the company's Park Ridge facility. This delivery order...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $5,581.44 by the Defense Logistics Agency (DLA) for the supply of Xolair 300 mg/2 ml syringes. The delivery order, issued on September 10, 2025, carries an ultimate completion date of October 1, 2025, with no set-aside designation applied. This award represents a specific task order issued under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,321.10 by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Xolair 150 mg/ml syringes. The contract, awarded without set-aside designation, carries a firm fixed-price structure with an ultimate completion date of September 18, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,547.40 by the Defense Logistics Agency (DLA) on August 29, 2025. The delivery order, which has an ultimate completion date of September 22, 2025, is for XOLAIR 150 mg/ml syringes. This award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open federal procurement...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $1,547.40 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 18, 2025, for XOLAIR 75 mg/0.5 mL syringes. The delivery order, which carries an ultimate completion date of October 9, 2025, was issued without a set-aside designation, allowing the company to compete directly in the open market. This award represents a discrete fulfillment...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,712.23 by the Defense Logistics Agency on August 15, 2025. The contract calls for delivery of Xolair 300 mg/2 mL auto-injector vials, a prescription medication used in the treatment of moderate-to-severe allergic asthma and chronic idiopathic urticaria. The delivery order carries an ultimate completion date of September 8,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,189.60 by the Defense Logistics Agency on September 2, 2025, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a potential value of $499,999,999 and remains valid through November...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $22,325.76 by the Defense Logistics Agency's Medical Supply Chain on August 22, 2025. The contract calls for the delivery of Xolair 300 mg/2 ml syringes and is expected to be completed by September 15, 2025. This delivery order was issued without a set-aside designation, demonstrating the company's competitive standing in...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,702.68 by the Defense Logistics Agency on September 3, 2025. The contract calls for the delivery of Xolair 75 mg/0.5 ml auto-injector syringes, with an ultimate completion date of September 24, 2025. This award was made without a set-aside designation, allowing the company to compete directly in the federal marketplace....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,547.40 by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, with an ultimate completion date of October 3, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, valued at...
- SPE2DB24D9131Indefinite Delivery Contract
- SPE2DB24D9131-SPE2DB25FXRT0Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $7,441.92 by the Defense Logistics Agency on August 13, 2025. The contract calls for the delivery of Xolair 300 mg/2 ml syringes, a biologic medication used primarily for severe allergic asthma and chronic urticaria treatment. This delivery order, which must be completed by September 4, 2025, was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a small business in the federal procurement marketplace. This award is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The parent contract, administered under the SPE2DB program, enables the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of medical product deliveries including prescription medications, biologics, vaccines, and specialty pharmaceuticals to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 8/13/25 |